Basel, 08 May 2017 Roche launches AVENIO ctDNA Analysis Kits for Oncology Research First blood-based distributed oncology tests covering all four mutation classes Three test choices provide accurate insights into different stages and types of cancer Streamlined testing generates results in five days Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced the global commercial launch of... Read more
Life Science companies, academic research institutions and biobanks can now achieve comprehensive visualization of biobank sample collection data with disparate databases Chelmsford, Mass. May 8, 2017 – Brooks Life Science Systems (Brooks) is launching its newest informatics platform, BioStudiesTM, to provide the industry’s most comprehensive purpose-built sample intelligence software system integrated with market leading enterprise... Read more
Uppsala, Sweden, 4 May, 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today the appointment of Mark Vossenaar as Vice President Sales, Europe, effective immediately. Mr. Vossenaar brings more than 25 years of experience in developing and leading life and health science commercial... Read more
AUSTIN, Texas, May 3, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES®Bordetella Assay for direct detection and identification of Bordetella pertussis (B. pertussis) and Bordetella parapertussis (B. parapertussis) nucleic acid in nasopharyngeal swab specimens obtained from individuals suspected of having a respiratory tract infection attributable to... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the company has completed the sale of its Medical Imaging business to Varex Imaging Corporation (Nasdaq: VREX). PerkinElmer announced its intent to sell its Medical Imaging business, a supplier of flat panel X-ray detectors that... Read more
Mass spectrometry identification solution may help hospitals manage antimicrobial resistance more effectively FRANKLIN LAKES, N.J., Apr. 27, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global distribution of a complete portfolio of products for mass spectrometry that provides high-speed and high-confidence identification of pathogens in... Read more
Download PDF Read more
Basel, 26 April 2017 New data at AAN reinforce clinical benefit of Roche’s OCREVUS™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis OCREVUS rapidly suppressed signs of disease activity in relapsing MS (RMS) patients In patients with early RMS – recently diagnosed and without prior treatment – OCREVUS was superior to Rebif® (interferon beta-1a) in... Read more
Investment Led by Khosla Ventures with Eye on Developing an Industry for Diagnostics Based on the 2PG Platform April 25, 2017 04:30 AM Pacific Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Two Pore Guys, Inc. (2PG), today announced the close of a Series A venture financing round in the amount of $24.5 million, led by Khosla Ventures.... Read more
Agreement includes exclusive distribution of PurePep Coupling Agents in North America Uppsala, Sweden, 25 April 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has signed an exclusive distribution agreement with Luxembourg Bio Technologies for two of its proprietary coupling agents, PyOxim®... Read more